Polymorphisms in the oligoadenylate synthetase gene cluster and its association with clinical outcomes of dengue virus infection.

[1]  Y. Liu,et al.  Polymorphisms of interferon-inducible genes OAS associated with interferon-α treatment response in chronic HBV infection. , 2011, Antiviral research.

[2]  A. G. Romaschenko,et al.  Variability in the 2'-5'-oligoadenylate synthetase gene cluster is associated with human predisposition to tick-borne encephalitis virus-induced disease. , 2010, The Journal of infectious diseases.

[3]  Ren-Jye Lin,et al.  Distinct Antiviral Roles for Human 2′,5′-Oligoadenylate Synthetase Family Members against Dengue Virus Infection1 , 2009, The Journal of Immunology.

[4]  J. Ward,et al.  Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in Man , 2009, PLoS pathogens.

[5]  Edgar Erdfelder,et al.  G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences , 2007, Behavior research methods.

[6]  A. Alcina,et al.  OAS1 gene haplotype confers susceptibility to multiple sclerosis. , 2006, Tissue antigens.

[7]  X. Solé,et al.  SNPStats: a web tool for the analysis of association studies , 2006, Bioinform..

[8]  Chun-Nan Hsu,et al.  FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization , 2006, Nucleic Acids Res..

[9]  B. Williams,et al.  A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase L. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[10]  F. Pociot,et al.  Variation in antiviral 2',5'-oligoadenylate synthetase (2'5'AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene. , 2005, American journal of human genetics.

[11]  M. Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[12]  M. Guzmán,et al.  Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. , 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[13]  P. Desprès,et al.  A nonsense mutation in the gene encoding 2′-5′-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[14]  I. Zhulin,et al.  Positional cloning of the murine flavivirus resistance gene , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[15]  D. Levy,et al.  The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. , 2001, Cytokine & growth factor reviews.

[16]  N. Kjeldgaard,et al.  Gene structure and function of the 2′-5′-oligoadenylate synthetase family , 2000, Cellular and Molecular Life Sciences CMLS.

[17]  Y. Shim.  Gene Structure and Function , 1998 .

[18]  D. Gubler,et al.  Dengue and Dengue Hemorrhagic Fever , 1998, Clinical Microbiology Reviews.

[19]  S. P. Akpabio.  World Health Organisation , 1983, British Dental Journal.